Institutional investors lightened up their holdings of ENZ shares during the quarter ended January 2015 as they sold a net -- shares. Additionally, the 46.14% of shares outstanding that remains in their hands is below average for companies in the Biotechnology industry and highlights that this company is not an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 2.1 Million shares of Enzo Biochem Inc